Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system

Future Microbiology

Volumn 10, Issue 6, 2015, Pages 955-965

  Backert, Steffen ^a   Tegtmeyer, Nicole ^a   Fischer, Wolfgang ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

c Met; CagA; CagL; cagPAI; CagY; cortactin; EGF receptor; gastric disease; GTPase; Helicobacter pylori; integrin; MARK2 PAR1b kinase; signaling; T4SS; type IV secretion; tyrosine kinases; VirB proteins; catenin

Indexed keywords

CAGA PROTEIN; IRON; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; TYPE IV SECRETION SYSTEM; VIRULENCE FACTOR;

ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL VIRULENCE; BACTERIUM PILUS; CAG REPEAT; CRYSTAL STRUCTURE; DISEASE COURSE; HELICOBACTER PYLORI; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TYPE IV SECRETION SYSTEM; BACTERIUM ADHERENCE; BIOLOGICAL MODEL; CHEMISTRY; EPITHELIUM CELL; GENETICS; GENOMIC ISLAND; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; NEGIBACTERIA;

ANTIGENS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; EPITHELIAL CELLS; GENOMIC ISLANDS; HELICOBACTER PYLORI; HUMANS; MODELS, BIOLOGICAL; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; TYPE IV SECRETION SYSTEMS; VIRULENCE FACTORS;

EID: 84930981461     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.32     Document Type: Article

References (65)

1. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 136(6), 1863-1873 (2009).
2. Salama NR, Hartung ML, Mueller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat. Rev. Microbiol. 11(6), 385-399 (2013).
3. Moodley Y, Linz B, Bond RP et al. Age of the association between Helicobacter pylori and man. PLoS Pathog. 8(5), e1002693 (2012).
4. Backert S, Clyne M, Tegtmeyer N. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Commun. Signal. 9, 28 (2011).
5. Gal-Mor O, Finlay BB. Pathogenicity islands: a molecular toolbox for bacterial virulence. Cell. Microbiol. 8(11), 1707-1719 (2006).
6. Censini S, Lange C, Xiang Z et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl Acad. Sci. USA 93(25), 14648-14653 (1996).
7. Pacchiani N, Censini S, Buti L et al. Echoes of a distant past: the cag pathogenicity island of Helicobacter pylori. Cold Spring Harb. Perspect. Med. 3(11), a010355 (2013).
8. Olbermann P, Josenhans C, Moodley Y et al. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet. 6(8), e1001069 (2010).
9. Kwok T, Zabler D, Urman S et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449(7164), 862-866 (2007).
10. Tegtmeyer N, Wessler S, Backert S. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278(8), 1190-1202 (2011).
11. Fischer W. Assembly and molecular mode of action of the Helicobacter pylori cag type IV secretion apparatus. FEBS J. 278(8), 1203-1212 (2011).
12. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immun. 58(3), 603-610 (1990).
13. Crabtree JE, Taylor JD, Wyatt JI et al. Mucosal IgA-recognition of Helicobacter 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338(8763), 332-335 (1991).
14. Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128-kDaimmunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl Acad. Sci. USA 90(12), 5791-5795 (1993).
15. D'Elios MM, Manghetti M, De Carli M et al. Thelper 1 effector cells specific for H. pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158(2), 962-967 (1997).
16. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA-positive or CagA-negative Helicobacter pylori infection. Gut 40(3), 297-301 (1997).
17. Alvarez-Martinez CE, Christie PJ. Biological diversity of prokaryotic type IV secretion systems. Microbiol. Mol. Biol. Rev. 73(4), 775-808 (2009).
18. Hare S, Fischer W, Williams R et al. Identification, structure and mode of action of a new regulator of the Helicobacter pylori H. pylori 0525 ATPase. EMBO J. 26(23), 4926-4934 (2007).
19. Cendron L, Seydel A, Angelini A et al. Crystal structure of CagZ, a protein from the Helicobacter pylori pathogenicity island that encodes for a Type IV Secretion System. J. Mol. Biol. 340(4), 881-889 (2004).
20. Cendron L, Tasca E, Seraglio T et al. The crystal structure of CagS from the Helicobacter pylori pathogenicity island. Proteins 69(2), 440-443 (2007).
21. Barden S, Lange S, Tegtmeyer N et al. A helical RGD motif promoting cell adhesion: crystal structures of the Helicobacter pylori type IV secretion system pilus protein CagL. Structure 21(11), 1931-1941 (2013).
22. Cendron L, Couturier M, Angelini A et al. The Helicobacter pylori CagD (H. pylori 0545, Cag24) protein is essential for CagA translocation and maximal induction of interleukin-8 secretion. J. Mol. Biol. 386(1), 204-217 (2009).
23. Kaplan-Türkoz B, Jiménez-Soto LF, Dian C et al. Structural insights into H. pylori oncoprotein CagA interaction with β1 integrin. Proc. Natl Acad. Sci. USA 109(36), 14640-14645 (2012).
24. Hayashi T, Senda M, Morohashi H et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe 12(1), 20-33 (2012).
25. Pham KT, Weiss E, Jiménez Soto LF et al. CagI is an essential component of the Helicobacter pylori Cag type IV secretion system and forms a complex with CagL. PLoS ONE 7(4), e35341 (2012).
26. Tanaka J, Suzuki T, Mimuro H, Sasakawa C. Structural definition on the surface of Helicobacter pylori type IV secretion apparatus. Cell. Microbiol. 5(6), 395-404 (2003).
27. Barrozo RM, Cooke CL, Hansen LM et al. Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathog. 9(2), e1003189 (2013).
28. Johnson EM, Gaddy JA, Voss BJ et al. Genes required for assembly of pili associated with the Helicobacter pylori cag type IV secretion system. Infect. Immun. 82(8), 3457-3470 (2014).
29. Shaffer CL, Gaddy JA, Loh JT et al. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLoS Pathog. 7(9), e1002237 (2011).
30. Fischer W, Püls J, Buhrdorf R et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42(5), 1337-1348 (2001).
31. Low HH, Gubellini F, Rivera-Calzada A et al. Structure of a type IV secretion system. Nature 508(7497), 550-553 (2014).
32. Kutter M, Buhrdorf R, Haas J et al. Protein subassemblies of the Helicobacter pylori Cag type IV secretion system revealed by localization and interaction studies. J. Bacteriol. 190(6), 2162-2171 (2008).
33. Pinto-Santini DM, Salama NR. Cag3 is a novel essential component of the Helicobacter pylori Cag type IV secretion system outer membrane subcomplex. J. Bacteriol. 191(23), 7343-7352 (2009).
34. Andrzejewska J, Lee SK, Olbermann P et al. Characterization of the pilin ortholog of the Helicobacter pylori type IV cag pathogenicity apparatus, a surface-associated protein expressed during infection. J. Bacteriol. 188(16), 5865-5877 (2006).
35. Hauck CR. Microbiology: preparing the shot. Nature 449(7164), 798-799 (2007).
36. Bonsor DA, Weiss E, Iosub-Amir A et al. Characterization of the translocationcompetent complex between the Helicobacter pylori oncogenic protein CagA and the accessory protein CagF. J. Biol. Chem. 288(46), 32897-32909 (2013).
37. Rohde N, Püls J, Buhrdorf R et al. A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol. Microbiol. 49(1), 219-234 (2003).
38. Noto JM, Gaddy JA, Lee JY et al. Iron deficiency accelerates Helicobacter pyloriinduced carcinogenesis in rodents and humans. J. Clin. Invest. 123(1), 479-492 (2013).
39. Tan S, Noto JM, Romero-Gallo J et al. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog. 7(5), e1002050 (2011).
40. Gaddy JA, Radin JN, Loh JT et al. The host protein calprotectin modulates the Helicobacter pylori cag type IV secretion system via zinc sequestration. PLoS Pathog. 10(10), e1004450 (2014).
41. Tegtmeyer N, Hartig R, Delahay RM et al. A small fibronectin-mimicking protein from bacteria induces cell spreading and focal adhesion formation. J. Biol. Chem. 285(30), 23515-23526 (2010).
42. Jiménez-Soto F, Kutter S, Sewald X et al. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGDindependent manner. PLoS Pathog. 5(12), e1000684 (2009).
43. Wiedemann T, Hofbaur S, Tegtmeyer N et al. Helicobacter pylori CagL dependent induction of gastrin expression via a novel vβ5-integrin-integrin linked kinase signaling complex. Gut 61(7), 986-996 (2012).
44. Backert S, Selbach M. Role of type IV secretion in Helicobacter pylori pathogenesis. Cell. Microbiol. 10(8), 1573-1581 (2008).
45. Murata-Kamiya N, Kikuchi K, Hayashi T et al. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 7(5), 399-411 (2010).
46. Chandran V, Fronzes R, Duquerroy S et al. Structure of the outer membrane complex of a type IV secretion system. Nature 462(7276), 1011-1015 (2009).
47. Neši D, Miller MC, Quinkert ZT et al. Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat. Struct. Mol. Biol. 17(1), 130-132 (2010).
48. Saadat I, Higashi H, Obuse C et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447(7142), 330-333 (2007).
49. Neši D, Buti L, Lu X, Stebbins CE. Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2. Proc. Natl Acad. Sci. USA 111(4), 1562-1567 (2014).
50. Franco AT, Israel DA, Washington MK et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl Acad. Sci. USA 102(30), 10646-10651 (2005).
51. Ohnishi N, Yuasa H, Tanaka S et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl Acad. Sci. USA 105(3), 1003-1008 (2008).
52. Glowinski F, Holland B, Thiede C et al. Analysis of T4SS-induced signaling by H. pylori using quantitative phosphoproteomics. Front. Microbiol. 5, 356 (2014).
53. Mueller D, Tegtmeyer N, Brandt S et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in western and east Asian Helicobacter pylori strains. J. Clin. Invest. 122(4), 1553-1566 (2012).
54. Selbach M, Paul FE, Brandt S et al. Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe 5(4), 397-403 (2009).
55. Higashi H, Tsutsumi R, Muto S et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295(5555), 683-686 (2002).
56. Tegtmeyer N, Wittelsberger R, Hartig R et al. Serine phosphorylation of cortactin controls focal adhesion kinase activity and cell scattering induced by Helicobacter pylori. Cell Host Microbe 9(6), 520-31 (2011).
57. Amieva MR, Vogelmann R, Covacci A et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300(5624), 1430-1434 (2003).
58. Churin Y, Al-Ghoul L, Kepp O et al. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell. Biol. 161(2), 249-255 (2003).
59. Poppe M, Feller SM, Römer G, Wessler S. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 26(24), 3462-3472 (2007).
60. Tammer I, Brandt S, Hartig R et al. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132(4), 1309-1319 (2007).
61. Backert S, Naumann M. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol. 18(11), 479-486 (2010).
62. Sokolova O, Maubach G, Naumann M. MEKK3 and TAK1 synergize to activate IKK complex in Helicobacter pylori infection. Biochim. Biophys. Acta 1843(4), 715-724 (2014).
63. Saha A, Backert S, Hammond CE et al. Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase alpha subunit. Gastroenterology 139(1), 239-248 (2010).
64. Belogolov E, Bauer B, Pompaiah M et al. Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell. Microbiol. 15(11), 1896-1912 (2013).
65. Viala J, Chaput C, Boneca IG et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5(11), 1166-1174 (2004).